Pituitary gland volume in patients with schizophrenia, subjects at ultra high-risk of developing psychosis and healthy controls: A systematic review and meta-analysis

[1]  C. Pariante,et al.  Stress abnormalities in individuals at risk for psychosis: A review of studies in subjects with familial risk or with “at risk” mental state , 2012, Psychoneuroendocrinology.

[2]  Christian Gaser,et al.  Heterogeneity of Brain Structural Variation and the Structural Imaging Endophenotypes in Schizophrenia , 2012, Neuropsychobiology.

[3]  R. Murray,et al.  Hypothalamic–pituitary–adrenal axis and clinical symptoms in first-episode psychosis , 2012, Psychoneuroendocrinology.

[4]  Vaughan J. Carr,et al.  Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia , 2012, Neuroscience & Biobehavioral Reviews.

[5]  R. Kahn,et al.  Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. , 2012, The international journal of neuropsychopharmacology.

[6]  R. Murray,et al.  Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. , 2011, The Journal of clinical psychiatry.

[7]  P. McGuire,et al.  Stress in people at high risk for psychosis , 2011, European psychiatry.

[8]  U. Gschwandtner,et al.  Pituitary volume increase during emerging psychosis , 2011, Schizophrenia Research.

[9]  Y. Kawasaki,et al.  Longitudinal volume changes of the pituitary gland in patients with schizotypal disorder and first-episode schizophrenia , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[10]  A. Riecher-Rössler,et al.  Estrogens and gonadal function in schizophrenia and related psychoses. , 2011, Current topics in behavioral neurosciences.

[11]  R. Murray,et al.  Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis , 2010, Psychological Medicine.

[12]  A. Grams,et al.  Female Pituitary Size in Relation to Age and Hormonal Factors , 2010, Neuroendocrinology.

[13]  Robin M. Murray,et al.  Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis , 2010, Schizophrenia Research.

[14]  R. Murray,et al.  Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment , 2010, Schizophrenia Research.

[15]  C. Pantelis,et al.  The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study , 2010, Schizophrenia Research.

[16]  C. Pantelis,et al.  Increased pituitary volume in schizophrenia spectrum disorders , 2009, Schizophrenia Research.

[17]  M. Large,et al.  Measurement and reporting of the duration of untreated psychosis , 2008, Early intervention in psychiatry.

[18]  R. Murray,et al.  Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder , 2008, Psychoneuroendocrinology.

[19]  A. Montejo.  Prolactin awareness: An essential consideration for physical health in schizophrenia , 2008, European Neuropsychopharmacology.

[20]  R. Stieglitz,et al.  Das Basel Screening Instrument für Psychosen (BSIP): Entwicklung, Aufbau, Reliabilität und Validität , 2008 .

[21]  K. Tessner,et al.  Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. , 2008, Annual review of clinical psychology.

[22]  C. Pariante.  Pituitary volume in psychosis: the first review of the evidence , 2008, Journal of psychopharmacology.

[23]  M. Walshe,et al.  P.3.a.006 Increased pituitary volume is a familial risk factor for schizophrenia but not for bipolar disorder , 2007, European Neuropsychopharmacology.

[24]  M. Keshavan,et al.  Effect of antipsychotics on pituitary gland volume in treatment-naïve first-episode schizophrenia: A pilot study , 2007, Schizophrenia Research.

[25]  M. Keshavan,et al.  Development and sexual dimorphism of the pituitary gland. , 2007, Life sciences.

[26]  M. Keshavan,et al.  Pituitary volume in neuroleptic-naïve schizophrenia: A structural MRI study , 2007, Schizophrenia Research.

[27]  A. Versace,et al.  Normal pituitary volumes in chronic schizophrenia , 2007, Psychiatry Research: Neuroimaging.

[28]  A. Yung,et al.  Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States , 2005 .

[29]  Peter B. Jones,et al.  Increased Pituitary Volume in Antipsychotic-Free and Antipsychotic-Treated Patients of the Æsop First-Onset Psychosis Study , 2005, Neuropsychopharmacology.

[30]  C. Pariante,et al.  Pituitary Volume Predicts Future Transition to Psychosis in Individuals at Ultra-High Risk of Developing Psychosis , 2005, Biological Psychiatry.

[31]  R. Murray,et al.  Pituitary volume in psychosis , 2004, British Journal of Psychiatry.

[32]  T. Mackeprang,et al.  Change in caudate nucleus volume after three-month treatment in drug-naive first-episode schizophrenia patients , 2004 .

[33]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[34]  Hok Pan Yuen,et al.  Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group , 2003, Schizophrenia Research.

[35]  Godfrey D Pearlson,et al.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. , 2003, Schizophrenia bulletin.

[36]  Hok Pan Yuen,et al.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. , 2002, Archives of general psychiatry.

[37]  A. Malla,et al.  Duration of untreated psychosis: a critical examination of the concept and its importance , 2001, Psychological Medicine.

[38]  G. Patton,et al.  Prediction of psychosis , 1998, British Journal of Psychiatry.

[39]  A. Riecher-Rössler,et al.  The course of schizophrenic psychoses: what do we really know? A selective review from an epidemiological perspective , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[40]  A. Elster,et al.  Modern imaging of the pituitary. , 1993, Radiology.

[41]  Orest B. Boyko,et al.  In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: Relationship to dexamethasone suppression test results in patients , 1992, Psychiatry Research.

[42]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[43]  J. Baxter,et al.  Glucocorticoid control of rat growth hormone gene expression: effect on cytoplasmic messenger ribonucleic acid production and degradation. , 1987, Molecular endocrinology.

[44]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[45]  K. Westlund,et al.  Quantification of morphological changes in pituitary corticotropes produced by in vivo corticotropin-releasing factor stimulation and adrenalectomy. , 1985, Endocrinology.

[46]  J. Zubin,et al.  Vulnerability--a new view of schizophrenia. , 1977, Journal of abnormal psychology.